Dialysis machine shortages lay bare wider Covid-19 threat

Memo to senior London doctors points to damage virus can do to other organs and strain on intensive care
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news

Related Links:

Hydroxychloroquine (HQ) has been used for the treatment of novel coronavirus disease (COVID-19) even though there is no clear evidence for its effectiveness yet. In contrary, HQ has major side effects like QTc prolongation and subsequent development of ventricular arrhythmias. Such side effects may possess additional risks on end-stage renal disease (ESRD) patients who have higher cardiovascular risks than general population. We herein present 2 cases of sudden cardiac death in 2 ESRD patients with COVID-19 for whom a treatment regimen including HQ was preferred. Both patients were clinically stable at the time of arrest. ...
Source: Blood Purification - Category: Hematology Source Type: research
The COVID-19 pandemic presents significant challenges for health systems globally, including substantive ethical dilemmas that may pose specific concerns in the context of care for people with kidney disease. Ethical concerns may arise as changes to policy and practice impact on the ability of all health professionals to fulfil their ethical duties towards their patients in providing best practice care. In this paper we briefly describe such concerns and elaborate on issues of particular ethical complexity in kidney care: equitable access to dialysis during pandemic surges; balancing the risks and benefits of different kid...
Source: Kidney International - Category: Urology & Nephrology Authors: Tags: review Source Type: research
In December 2019, cases of acute respiratory illness of unknown origin were reported in Wuhan, China. The disease is caused by “severe acute respiratory syndrome coronavirus 2”. After identifying severe lung damage, injury to other organs, such as the kidney, has been identified. Peritoneal dialysis is a renal replacement therapy (RRT) and is at least as effective as other extracorporeal therapy options, with significan t cost-effective advantages. However, this strategy is rarely used for the management of acute kidney injury in severe lung disease. In this review, we explore PD as an RRT strategy that may be ...
Source: Blood Purification - Category: Hematology Source Type: research
Authors: Al-Hwiesh AK, Mohammed AM, Elnokeety M, Al-Hwiesh A, Al-Audah N, Esam S, Abdul-Rahman IS Abstract Coronavirus Disease 2019 (COVID-19) is a pandemic disease that increased the burden on health-care system. In the Kingdom of Saudi Arabia, 74,795 cases have been reported until 26 May 2020 and the number of cases is rapidly increasing. The mortality rate of COVID-19 worldwide is 6.37%. Here we report three cases of acute kidney injury (AKI) secondary to pneumonia of severe COVID-19; they were treated with automated peritoneal dialysis (PD) with full recovery. To the best of our knowledge, few reports in the li...
Source: Peritoneal Dialysis International - Category: Urology & Nephrology Tags: Perit Dial Int Source Type: research
Authors: Wilkie M PMID: 32998643 [PubMed - in process]
Source: Peritoneal Dialysis International - Category: Urology & Nephrology Tags: Perit Dial Int Source Type: research
Publication date: Available online 1 October 2020Source: American Journal of Kidney DiseasesAuthor(s): Daisuke Hirai, Daisuke Yamashita, Koichi Seta
Source: American Journal of Kidney Diseases - Category: Urology & Nephrology Source Type: research
Publication date: Available online 28 September 2020Source: American Journal of Kidney DiseasesAuthor(s): Susie Q. Lew, Eric L. Wallace, Vesh Srivatana, Bradley A. Warady, Suzanne Watnick, Jayson Hood, David L. White, Vikram Aggarwal, Caroline Wilkie, Mihran V. Naljayan, Mary Gellens, Jeffrey Perl, Martin J. Schreiber
Source: American Journal of Kidney Diseases - Category: Urology & Nephrology Source Type: research
Treatment of COVID-19 atypical pneumonia by early Tocilizumab administration in "non-critically-ill" patients on hemodialysis. J Nephrol. 2020 Sep 30;: Authors: Castellano G, Infante B, Mercuri S, Forcella M, Cox SN, Serviddio G, Gesualdo L, Stallone G PMID: 32997331 [PubMed - as supplied by publisher]
Source: Journal of Nephrology - Category: Urology & Nephrology Authors: Tags: J Nephrol Source Type: research
Authors: Deshpande R, Dash S, Bahadur MM, Thamba A, Pathan AK, Dave K, Chaudhari C, Shringare A, Patil A Abstract COVID-19 has emerged as a pandemic of significance with potential to cause significant morbidity and mortality worldwide. Elderly with or without following comorbidities i.e Diabetes, hypertension, cardiac disease, chronic respiratory illnesses, chronic liver disease, CKD, malignancy and immunocompromised hosts are at increased risk of developing complicated course. Hemodialysis population hence are at increased risk for contracting the infection due to patient characteristics, environmental characteris...
Source: Journal of the Association of Physicians of India - Category: General Medicine Tags: J Assoc Physicians India Source Type: research
Fewer than 1 in 10 dialysis patients sampled had antibodies against the novel coronavirus as of July, indicating that the greater population is far from levels required to achieve herd immunity.
Source: The Scientist - Category: Science Tags: News & Opinion Source Type: news
More News: COVID-19 | Dialysis | Intensive Care | Pharmaceuticals